Browse Category

Stock Market News 19 October 2025

AI Boom’s Hidden Gem: Credo (CRDO) Stock Soars on $500 “Purple” Cables and Big Partnerships

AI Boom’s Hidden Gem: Credo (CRDO) Stock Soars on $500 “Purple” Cables and Big Partnerships

CRDO’s Wild Ride on AI Hype Credo (NASDAQ: CRDO) has become one of 2025’s hottest AI infrastructure stocks. The company makes advanced cables and chips that connect GPUs inside AI supercomputers. In late September, Elon Musk’s xAI even showcased “thousands”
Shocking U-Turn: Social Security Paper Checks Saved – Trump’s Stimulus Check Hype Debunked, Stocks Soar

Shocking U-Turn: Social Security Paper Checks Saved – Trump’s Stimulus Check Hype Debunked, Stocks Soar

What’s Behind the Paper-Check Change? In March 2025 President Trump signed an executive order (EO 14247) directing agencies to “eliminate physical payments…to the extent permitted by law” kiplinger.com. By late summer, Treasury and SSA announced a Sept. 30 deadline to switch
Coca-Cola (KO) Stock Rockets on Board Shake-Up and Bold Moves – What Investors Need to Know

Coca-Cola (KO) Stock Rockets on Board Shake-Up and Bold Moves – What Investors Need to Know

Sources: Recent Reuters and MarketBeat analyses, and The Coca-Cola Company’s own filings and press releases (cited above), provide the data and quotes used herein reuters.com reuters.com investors.coca-colacompany.com reuters.com ts2.tech. The market data reflect trading as of Oct. 17, 2025.
CRISPR Therapeutics Stock Explodes on Gene-Editing Breakthroughs – Analysts See 35% Upside

CRISPR Therapeutics Stock Explodes on Gene-Editing Breakthroughs – Analysts See 35% Upside

Clinical and Pipeline Progress CRISPR Therapeutics has reported a string of positive R&D updates in recent weeks. On October 10, 2025, CRSP presented preclinical results for CTX460, its SyNTase-based therapy for alpha-1 antitrypsin deficiency (AATD). The data – highlighted at
1 800 801 802 803 804 892
Go toTop